flufenamic acid has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Domínguez-Luis, M | 1 |
Herrera-García, A | 1 |
Arce-Franco, M | 1 |
Armas-González, E | 1 |
Rodríguez-Pardo, M | 1 |
Lorenzo-Díaz, F | 1 |
Feria, M | 1 |
Cadenas, S | 1 |
Sánchez-Madrid, F | 1 |
Díaz-González, F | 1 |
1 other study available for flufenamic acid and Autosomal Recessive Chronic Granulomatous Disease
Article | Year |
---|---|
Superoxide anion mediates the L-selectin down-regulation induced by non-steroidal anti-inflammatory drugs in human neutrophils.
Topics: ADAM Proteins; ADAM17 Protein; Adolescent; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Co | 2013 |